Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Column Performance Qualification – V 2.0

Posted on By

BA-BE Studies: SOP for Column Performance Qualification – V 2.0

Standard Operating Procedure for Column Performance Qualification in BA/BE LC-MS/MS Analysis

Department BA-BE Studies
SOP No. SOP/BA-BE/190/2025
Supersedes SOP/BA-BE/190/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for qualification and monitoring of analytical column performance used in LC-MS/MS methods during BA/BE studies, ensuring consistent chromatographic behavior, reproducibility, and regulatory compliance.

2. Scope

This SOP applies to all reversed-phase analytical columns used in validated bioanalytical LC-MS/MS methods conducted for BA/BE studies in the bioanalytical department.

3. Responsibilities

  • Bioanalytical Analyst: Responsible for performing column qualification and monitoring performance per method-specific
criteria.
  • QA Officer: Reviews column qualification records and investigates deviations or failures.
  • Lab Manager: Ensures traceability of column usage and qualification records.
  • 4. Accountability

    The Head of Bioanalytical Department is accountable for ensuring proper qualification, performance monitoring, and replacement of columns in accordance with this SOP.

    5. Procedure

    5.1 Column Receipt and Inventory

    1. Receive column from approved vendor with Certificate of Analysis (CoA).
    2. Verify physical condition and label with a unique Column ID.
    3. Record details in Annexure-1: Column Inventory Log including:
      • Column type
      • Serial number
      • Dimensions
      • Lot number
      • Date of receipt

    5.2 Initial Column Qualification

    1. Flush the column with recommended solvents (e.g., methanol, water, acetonitrile) to remove shipping preservatives.
    2. Equilibrate the column with mobile phase used in the validated method.
    3. Run 5 replicates of a standard solution or system suitability solution.
    4. Evaluate performance parameters:
      • Retention time consistency (RSD ≤ 2%)
      • Theoretical plates ≥ method-specified limit
      • Tailing factor ≤ 2.0
      • Resolution between analyte and IS ≥ 2.0
    5. Document results in Annexure-2: Column Qualification Report.

    5.3 Routine Column Usage and Monitoring

    1. Log every use of the column including:
      • Date of use
      • Run ID
      • Number of injections
      • Analyst name
    2. Monitor performance weekly or every 500 injections (whichever comes first).
    3. Check chromatograms for:
      • Peak symmetry
      • Baseline noise
      • Drift or pressure changes
    4. Document observations in Annexure-3: Column Usage and Monitoring Log.

    5.4 Column Regeneration and Disposal

    1. Regenerate columns by back-flushing with strong solvent if performance declines.
    2. If regeneration fails or column is damaged:
      • Mark column as ‘Out of Use’
      • Dispose as per lab’s hazardous waste SOP
      • Record in Annexure-4: Column Disposition Log

    6. Abbreviations

    • BA/BE: Bioavailability/Bioequivalence
    • LC-MS/MS: Liquid Chromatography Tandem Mass Spectrometry
    • IS: Internal Standard
    • RSD: Relative Standard Deviation
    • SOP: Standard Operating Procedure

    7. Documents

    1. Column Inventory Log – Annexure-1
    2. Column Qualification Report – Annexure-2
    3. Column Usage and Monitoring Log – Annexure-3
    4. Column Disposition Log – Annexure-4

    8. References

    • ICH M10: Bioanalytical Method Validation
    • US FDA Bioanalytical Method Validation Guidance (2022)
    • USP General Chapter <621>: Chromatography

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Column Inventory Log

    Column ID Type Dimensions Lot No. Received Date
    COL-BAE-001 C18 50×2.1mm, 3µm LT202504 12/04/2025

    Annexure-2: Column Qualification Report

    Column ID RT RSD (%) Plates Tailing Factor Resolution Status
    COL-BAE-001 1.2% 6500 1.1 2.5 Qualified

    Annexure-3: Column Usage and Monitoring Log

    Date Run ID No. of Injections Observations Initials
    15/04/2025 BAE-102 96 Normal performance RK

    Annexure-4: Column Disposition Log

    Column ID Disposed Date Reason Disposed By Verified By
    COL-BAE-001 15/10/2025 High backpressure Sunita Reddy QA Officer

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial Issue New SOP QA Head
    17/04/2025 2.0 Enhanced qualification and lifecycle tracking Regulatory Update QA Head
    See also  BA-BE Studies: SOP for Handling Analytical Equipment Breakdowns - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: SOP for FDA 510(k) Submission Preparation
    Next Post: API Manufacturing: SOP for Handling of Returned Drug Product – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version